Guggenheim raised the firm’s price target on Accolade to $18 from $16 and keeps a Buy rating on the shares. Following what the firm describes as "a solidly in-line quarter," it thinks that overall trends remains favorable for Accolade. However, the firm believes the Q1 guidance coming in below consensus was "the primary culprit" for the stock was down in after hours trading as it thinks there "likely was some hope for more of a beat and raise."
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ACCD: